Michael Golembiewski
2023
In 2023, Michael Golembiewski earned a total compensation of $846.7K as Chief Financial Officer at Apricus Biosciences, a 21% decrease compared to previous year.
Compensation breakdown
| Option Awards | $458,467 |
|---|---|
| Salary | $375,000 |
| Other | $13,200 |
| Total | $846,667 |
Golembiewski received $458.5K in option awards, accounting for 54% of the total pay in 2023.
Golembiewski also received $375K in salary and $13.2K in other compensation.
Rankings
In 2023, Michael Golembiewski's compensation ranked 1,399th out of 3,006 executives tracked by ExecPay. In other words, Golembiewski earned more than 53.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,399 out of 3,006 | 54th |
Division Manufacturing | 834 out of 1,650 | 50th |
Major group Chemicals And Allied Products | 547 out of 918 | 40th |
Industry group Drugs | 534 out of 881 | 39th |
Industry Pharmaceutical Preparations | 373 out of 637 | 41st |
Source: SEC filing on August 20, 2024.
Golembiewski's colleagues
We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2023.
2023
Raj Mehra
Apricus Biosciences